{"schema_version":"secwatch.filing_event.v1","accession":"0001628908-25-000069","form_type":"8-K","ticker":"EVH","cik":"0001628908","company_name":"Evolent Health, Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.123167+00:00","generated_at":"2026-05-20T01:41:10.865833+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Evolent Health reaffirms FY2025 revenue guidance of $2.06B-$2.11B at William Blair conference","bullets":["Reaffirms FY2025 revenue guidance of $2.06B-$2.11B and Adjusted EBITDA of $135M-$165M.","Q2 2025 revenue guidance reaffirmed at $440M-$470M; Adj EBITDA $33M-$40M.","Guidance unchanged from the May 8, 2025 press release; no new financial targets."],"urls":{"canonical":"https://secwatch.observer/filing/0001628908-25-000069","json":"https://secwatch.observer/filing/0001628908-25-000069.json","markdown":"https://secwatch.observer/filing/0001628908-25-000069.md","text":"https://secwatch.observer/filing/0001628908-25-000069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000069/0001628908-25-000069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000069/evh-20250603.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:41:10.865833+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}